Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.

Lawn SD, Meintjes G, McIlleron H, Harries AD, Wood R.

BMC Med. 2013 Dec 2;11:253. doi: 10.1186/1741-7015-11-253. Review.

PMID:
24295487
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Management of individuals requiring antiretroviral therapy and TB treatment.

Cohen K, Meintjes G.

Curr Opin HIV AIDS. 2010 Jan;5(1):61-9. doi: 10.1097/COH.0b013e3283339309. Review.

PMID:
20046149
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.

Van Rie A, Patel MR, Nana M, Vanden Driessche K, Tabala M, Yotebieng M, Behets F.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e110-7. doi: 10.1097/01.qai.0000434954.65620.f3.

PMID:
24091692
[PubMed - indexed for MEDLINE]
4.

Tuberculosis and HIV co-infection: screening and treatment strategies.

Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH.

Drugs. 2011 Jun 18;71(9):1133-52. doi: 10.2165/11591360-000000000-00000. Review.

PMID:
21711060
[PubMed - indexed for MEDLINE]
5.

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 – CIPRA KH001) Study Team.

AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7.

PMID:
24096631
[PubMed - indexed for MEDLINE]
6.

Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.

Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Schünemann HJ, Royce S, Dheda K, Walson JL; ART study group.

PLoS One. 2012;7(11):e47370. doi: 10.1371/journal.pone.0047370. Epub 2012 Nov 5. Review.

PMID:
23144818
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.

Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV.

J Int AIDS Soc. 2012;15(2):17396. Review.

PMID:
22905358
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.

Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Chhi Vun M, French MA.

J Infect Dis. 2009 Dec 1;200(11):1736-45. doi: 10.1086/644784.

PMID:
19874177
[PubMed - indexed for MEDLINE]
Free Article
9.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
[PubMed - indexed for MEDLINE]
10.

The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome.

Lai RP, Nakiwala JK, Meintjes G, Wilkinson RJ.

Eur J Immunol. 2013 Aug;43(8):1995-2002. doi: 10.1002/eji.201343632. Review.

PMID:
23928963
[PubMed - indexed for MEDLINE]
11.

Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.

Lee SS, Meintjes G, Kamarulzaman A, Leung CC.

Respirology. 2013 Aug;18(6):912-22. doi: 10.1111/resp.12120. Review.

PMID:
23682586
[PubMed - indexed for MEDLINE]
Free Article
12.

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R.

Int J Tuberc Lung Dis. 2011 May;15(5):571-81. doi: 10.5588/ijtld.10.0483.

PMID:
21756508
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.

Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, Koole O, Mayanja-Kizza H, Kestens L, Mugerwa R, Reiss P, Colebunders R; TB-IRIS Study Group.

Antivir Ther. 2012;17(5):841-8. doi: 10.3851/IMP2108. Epub 2012 Apr 27.

PMID:
22543224
[PubMed - indexed for MEDLINE]
14.

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C; Paradox-TB Study Group.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1365-70. doi: 10.5588/ijtld.11.0693. Erratum in: Int J Tuberc Lung Dis. 2014 Jun;18(6):754. Elmarsafy, S [corrected to El Marsafy, S]. Int J Tuberc Lung Dis. 2012 Dec;16(12):1712. ANRS-EP21 (Agence Nationale de Recherche sur le Sida) Paradox TB Study Group [corrected to Paradox-TB Study Group].

PMID:
23107635
[PubMed - indexed for MEDLINE]
15.

Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia.

Miyano S, Dube C, Kayama N, Ishikawa N, Nozaki I, Syakantu G.

Int J Tuberc Lung Dis. 2013 Apr;17(4):540-5. doi: 10.5588/ijtld.12.0432. Epub 2013 Feb 7.

PMID:
23394080
[PubMed - indexed for MEDLINE]
16.

API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.

API Consensus Expert Committee.

J Assoc Physicians India. 2006 Mar;54:219-34.

PMID:
16800350
[PubMed - indexed for MEDLINE]
17.

Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.

van Maaren PJ.

Kekkaku. 2010 Jan;85(1):9-16.

PMID:
20143671
[PubMed - indexed for MEDLINE]
18.

Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study.

Sinha S, Raghunandan P, Chandrashekhar R, Sharma SK, Kumar S, Dhooria S, Ekka M, Velpandian T, Ranjan S, Ahmad H, Samantaray JC, Venkatesh S, Rewari BB, Khan NH, Pandey RM.

BMC Infect Dis. 2013 Oct 17;13:482. doi: 10.1186/1471-2334-13-482.

PMID:
24134449
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.

Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J; Adult AIDS Clinical Trials Group A5221 Study Team.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):423-8. doi: 10.1097/QAI.0000000000000030.

PMID:
24226057
[PubMed - indexed for MEDLINE]
20.

The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.

Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ.

AIDS. 2014 Jan;28 Suppl 1:S25-34. doi: 10.1097/QAD.0000000000000085.

PMID:
24468944
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk